Management ChangeApr 30, 2026, 05:17 PM
PCSA Chief Development & Regulatory Officer Transitions to Part-Time
AI Summary
Processa Pharmaceuticals, Inc. announced that Dr. Sian Bigora, Chief Development and Regulatory Officer, will transition from a full-time executive officer role to a part-time employee position, effective May 1, 2026. This change is part of her planned transition toward retirement. She will no longer be designated an "executive officer" but will retain her title and continue to provide services in a reduced capacity. Her employment agreement will be replaced, and her equity awards and bonus compensation will remain subject to their original terms.
Key Highlights
- Dr. Sian Bigora transitions from full-time executive to part-time employee.
- Effective date for the transition is May 1, 2026.
- Dr. Bigora will no longer be designated an "executive officer" under Section 16.
- She will retain her title as Chief Development and Regulatory Officer.
- Her existing employment agreement terminates, replaced by a new part-time arrangement.
- Equity awards and previously awarded bonus compensation remain subject to original terms.
Price Impact
More from PCSA